Equity Research Analyst
Kki Capital
New York, New York, United States
• Covered 6 targeted companies in the healthcare industry and conducted comprehensive market, industry, and company research for investment evaluation, ensuring comparability for competitor analysis• Performed financial ratio analysis, assessing historical performance metrics including P/E, ROE, leverage ratio, profit margins, and other relevant ratios/metrics, referencing their latest annual/quarterly reports • Implemented SWOT, PEST, and Porter's 5 Forces to analyze the impact of political, social, market, and firm-specific factors on targeted companies’ sales, CAPEX, and financing activities over the next 3-5 years for valuation purposes• Developed DCF and CCA valuation models in MS Excel to assess industrial top performers, directly informing strategic investments in 2 companies, which are projected to outperform the benchmark index by 4.5% and 9.12% in 2024, respectively• Constructed a Capital Asset Pricing Model (CAPM) to analyze historical returns and volatility of selected assets relative to the market• Conducted daily market surveillance, tracking selected assets' performance, emerging trends, and policy shifts, drafted buy-side reports and sales pitches for weekly presentations.